Proto Labs Inc: Form 10-K for the period ended Dec 31, 2020
Filed with the SEC on Feb 19, 2021 and accepted by EDGAR at Feb 19, 2021, 15:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | $434.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months2020-01-01 to 2020-12-31 | $216.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2020-01-01 to 2020-12-31 | $217.8m | us-gaap:GrossProfit |
| Research and development | 12 months2020-01-01 to 2020-12-31 | $36.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $59.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $12.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-01-01 to 2020-12-31 | $50.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $1.89 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $1.90 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 26,896,357 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $107.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $47.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2020-01-01 to 2020-12-31 | $14.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $127.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $242.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $744.2m | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $50.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $99.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $644.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-21-003413. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.